BullFrog AI (BFRG) announced a commercial agreement with a global pharmaceutical company to apply the company’s proprietary bfLEAP platform to identify and prioritize novel drug targets in major depressive disorder, accelerating the customer’s drug discovery and clinical development program for this indication. The agreement also provides exclusive access to a target candidate
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BFRG: